-
$161 million! China Biopharmaceutical completes acquisition of F-star Therapeutics
The transaction will enable invoX to invest in and develop F-star's bispecific antibody platform as the backbone of future cancer immunotherapy.
2023-03-10 09:52 -
Cypress Biology: more than 100 million yuan of PreA round financing, accelerate the development o...
Recent progress in cypress biology.
2023-03-10 09:50 -
RSV vaccine $10 billion market Battle: Divided by 2023
Antigen selection is an important factor in determining the effectiveness of a vaccine.
2023-03-08 11:44 -
The chip maker went after the body parts
Hopefully, more and more crossover talent will emerge.
2023-03-08 11:40 -
ACS Med. Chem. Lett. | PROTAC targeted FLT3 - ITD proteins: new therapy of acute myeloid leukemia
A new treatment for acute myeloid leukemia!
2023-03-02 14:01 -
At present, many domestic enterprises have carried out differentiation transformation on allogeneic...
At present, many domestic enterprises have carried out differentiation transformation on allogeneic CAR-T to explore new ways out.
2023-03-02 13:57 -
What is the secret of vant Empire, which was founded eight years ago and has incubated more than 20 ...
Legendary company of legendary people
2023-03-02 13:55 -
For the first time, heparin was incorporated into the country, which ushered in a change in the ten-...
Will heparin domestic five male Pattern change?
2023-02-27 14:54 -
To accelerate the development of smart medical examination, Kingdomain Medical signed a strategic co...
Digital technologies will help promote the high-quality development of medical and health care.
2023-02-27 14:51 -
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- Covestro and Wanhua Reshape Gl... Aug 20, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- Glenmark Recalls Over 110000 B... Aug 24, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products
Related Producers
